However, in contrast to breast tumor tissues that mostly expressed low levels of CD56, 60% of breast normal tissues were found to express high levels of CD56, 10% expressed moderate levels of CD56 and 30% expressed very low levels of CD56 (Supplementary Fig. 2). This evidence concerns the gene NCAM1 and breast neoplasm.